Mali vs South Sudan: Average cost of multi drug-resistant tuberculosis treatment
Mali
709 constant 2022 US$
in 2024
South Sudan
682 constant 2022 US$
in 2024
Mali rank
67th
South Sudan rank
69th
Average cost of multi drug-resistant tuberculosis treatment over time
- Mali
- South Sudan
How they compare
Mali currently reports 709 constant 2022 US$ against 682 constant 2022 US$ in South Sudan, a difference of 27 constant 2022 US$.
The two have swapped places 2 times across 5 shared years of data; in 2019 it was Mali ahead.
Mali ranks 67th and South Sudan ranks 69th of 92 countries.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mali | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8,674 constant 2022 US$ | 1,678 constant 2022 US$ | 6,996 constant 2022 US$ | Mali |
| 2020s | 18,173 constant 2022 US$ | 2,042 constant 2022 US$ | 16,131 constant 2022 US$ | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Mali or South Sudan?
- Mali, at 709 constant 2022 US$ against 682 constant 2022 US$ in South Sudan as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Mali and South Sudan?
- 27 constant 2022 US$, with Mali ahead.
- How many years of comparable data are there for Mali and South Sudan?
- 5 years are reported by both, from 2019 to 2024.
- How do Mali and South Sudan rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Mali ranks 67th and South Sudan ranks 69th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.